Novo Nordisk has launched a big integrated Spanish-language campaign for its FlexPen insulin delivery device—one that Univision calls “the most robust ever” in Hispanic media for the diabetes sector.
“It's a portfolio play across all our brands,” said Novo Nordisk's Jeremy Shepler, associate director of marketing. “What we learned that initiated this effort was that the prevalence of type 2 diabetes among Hispanics is quite large, 2.4 times greater than among non-Hispanic whites.”
A tracking survey the company ran found just 9% unaided awareness of insulin delivery devices among Hispanics with diabetes. For insulin users, awareness was a little higher at 15%.
FlexPen straddles Novo Nordisk's insulin portfolio, which includes Novolog and Levemir. The TV component, with ads airing on channels including Univision, Telemundo and Telefutura, is specific to Novolog FlexPen, but other parts, including online promotion, will plug both brands. Cult Health handled creative in partnership with Miami-based Hispanic marketing specialist DMG Solutions.
The tagline is “Administracion de insulina que va contigo”—in English, “Insulin delivery that's going places.” The tagline for English-language ads is “Insulin delivery my way.”
Digital efforts go beyond banner ads, with a website (miflexpen.com), relationship marketing and paid search.
“Understanding the 12.3% diabetes prevalence rate for Hispanics versus 8.4% for non-Hispanics and the tremendous opportunity to reach a consumer that can drive demand for their product, FlexPen has taken a strategic approach to engage with the Latino consumer directly in Spanish,” said Jorge Daboub, VP for Univision's Client Development Group. “This is the most robust diabetes campaign ever targeting Hispanic Americans and it is the first integrated DTC campaign leveraging both TV and digital media.”
“To have something so integrated across languages is new,” said Shepler.
A recent Univision study of predominately Spanish-speaking American patients found a need for more in-culture communications about health and medicine, noting that Hispanics are 21% less likely to be diagnosed with disease than non-Hispanics.